Biological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement Post author:GHIAA Admin Post published:March 2, 2022 Post category: Continue ReadingBiological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:January 3, 2022 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
Merck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingMerck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
Merck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingMerck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
Merck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement Post author:GHIAA Editor Post published:May 22, 2020 Post category: Continue ReadingMerck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement